Clinical Trials Browser

Phase 2 × INDUSTRY × Leiomyoma × Clear all

NCT01441635 2021-07-13

Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids

Phase 2 Completed

271 enrolled 38 charts

Leiomyoma, Menorrhagia

NCT01817530 2020-07-21

Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

Phase 2 Completed

571 enrolled 32 charts

Leiomyoma, Menorrhagia

NCT02811159 2019-06-27

An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids

Phase 2 Terminated

20 enrolled 16 charts

Leiomyoma

NCT02323646 2019-06-25

Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids

Phase 2 Completed

42 enrolled 22 charts

Fibroma, Leiomyoma

NCT02301897 2019-06-19

A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids

Phase 2 Completed

43 enrolled 21 charts

Leiomyoma

NCT00958334 2019-06-18

Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

Phase 2 Completed

65 enrolled 10 charts

Leiomyoma

NCT03550703 2018-07-06

V3-myoma

Phase 2 Unknown

Fibroma, Leiomyoma, Myofibroma

NCT02131662 2017-12-08

ASTEROID 1

Phase 2 Completed

309 enrolled 24 charts

Leiomyoma

NCT02465814 2016-11-22

ASTEROID 2

Phase 2 Completed

Leiomyoma, Menorrhagia

NCT01451424 2014-08-29

Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids

Phase 2 Completed

40 enrolled 14 charts

Leiomyoma

NCT00958893 2014-08-25

An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext

Phase 2 Terminated

4 enrolled 1 chart

Leiomyoma

NCT00683917 2014-08-21

Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

Phase 2 Terminated

10 enrolled 1 chart

Leiomyoma

NCT00882258 2014-07-08

Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

Phase 2 Completed

Leiomyoma

NCT01631903 2014-04-16

Extension of Study ZPV-200

Phase 2 Completed

Leiomyoma

NCT01739621 2014-04-16

Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200

Phase 2 Completed

Leiomyoma

NCT01452659 2013-01-21

Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids

Phase 2 Completed

Leiomyoma

NCT00881140 2012-12-19

Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids

Phase 2 Completed

Leiomyoma, Uterine Hemorrhage

NCT00776074 2010-06-22

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

Phase 2 Completed

Leiomyoma, Uterine Neoplasms

NCT00156182 2009-03-04

A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.

Phase 2 Completed

Leiomyoma

NCT00150644 2008-05-29

A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy

Phase 2 Completed

Leiomyoma

NCT00160459 2008-05-29

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

Phase 2 Completed

Leiomyoma